Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Gastrointestinal 2Sarcoma 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Prostatic Neoplasms 7Breast Neoplasms 5Ovarian Neoplasms 4Pancreatic Neoplasms 3Colorectal Neoplasms, Hereditary Nonpolyposis 3Triple Negative Breast Neoplasms 2Neoplastic Syndromes, Hereditary 2Hereditary Breast and Ovarian Cancer Syndrome 2Endometrial Neoplasms 2Colorectal Neoplasms 2Urogenital Neoplasms 1Sarcoma 1Rectal Neoplasms 1Neoplasms, Unknown Primary 1Neoplasm Metastasis 1Multiple Myeloma 1Melanoma 1Lymphoproliferative Disorders 1Kidney Neoplasms 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Fanconi Anemia, Complementation Group D1 1Digestive System Neoplasms 1Cytopenia 1Congenital Bone Marrow Failure Syndromes 1Colonic Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Intraductal, Noninfiltrating 1Cancer Risk Syndrome 1

Interventions

Oxaliplatin 270Bevacizumab 260Fluorouracil 249Irinotecan 240Leucovorin 218Capecitabine 196Cetuximab 161Colonoscopy 74Folfox protocol 70Panitumumab 64regorafenib 62Drug Therapy 52Radiotherapy 50HMPL-013 50Blood Specimen Collection 45trifluridine tipiracil drug combination 43pembrolizumab 41Surveys and Questionnaires 35Standard of Care 35Nivolumab 34Neoadjuvant Therapy 34Surgical Procedures, Operative 33Magnetic Resonance Spectroscopy 31IFL protocol 27Trifluridine 26Interviews as Topic 26Celecoxib 26XELOX 25Early Intervention, Educational 24Specimen Handling 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Colorectal Neoplasms × Genetic Counseling × Clear all
NCT05225428 2026-05-22

VERDI

Dana-Farber Cancer Institute

Phase NA Recruiting
1,020 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Kidney Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Colorectal Neoplasms

NCT01850654 2018-06-28

OCCPI

Ohio State University Comprehensive Cancer Center

Phase NA Completed
3,470 enrolled
GastrointestinalGynecologic

Colonic Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Rectal Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡